Shen C, Liang D, Wang X, Shao W, Geng K, Wang X
Front Pharmacol. 2022; 13:1013432.
PMID: 36278167
PMC: 9579312.
DOI: 10.3389/fphar.2022.1013432.
Leonard J, Tan Y, Gilbert M, Isaacs K, El-Masri H
Toxicol Sci. 2016; 151(1):57-70.
PMID: 26865668
PMC: 4914794.
DOI: 10.1093/toxsci/kfw022.
Darwich A, Henderson K, Burgin A, Ward N, Whittam J, Ammori B
Br J Clin Pharmacol. 2012; 74(5):774-87.
PMID: 22463107
PMC: 3495142.
DOI: 10.1111/j.1365-2125.2012.04284.x.
Kabanda L, Lefebvre R, Van Bree H, Remon J
Pharm Res. 1994; 11(11):1663-8.
PMID: 7870687
DOI: 10.1023/a:1018982409661.
Kampmann J, Molholm Hansen J
Br J Clin Pharmacol. 1981; 12(5):681-6.
PMID: 7332734
PMC: 1401968.
DOI: 10.1111/j.1365-2125.1981.tb01289.x.
Ampicillin and propylthiouracil pharmacokinetics in intestinal bypass patients followed up to a year after operation.
Kampmann J, Klein H, Lumholtz B, Molholm Hansen J
Clin Pharmacokinet. 1984; 9(2):168-76.
PMID: 6713763
DOI: 10.2165/00003088-198409020-00004.
Mean residence time in peripheral tissue: a linear disposition parameter useful for evaluating a drug's tissue distribution.
Veng-Pedersen P, Gillespie W
J Pharmacokinet Biopharm. 1984; 12(5):535-43.
PMID: 6520747
DOI: 10.1007/BF01060131.
Pharmacokinetics of antithyroid drugs.
Benker G, REINWEIN D
Klin Wochenschr. 1982; 60(11):531-9.
PMID: 6180218
DOI: 10.1007/BF01724208.
Clinical pharmacokinetics of antithyroid drugs.
Kampmann J, Hansen J
Clin Pharmacokinet. 1981; 6(6):401-28.
PMID: 6172233
DOI: 10.2165/00003088-198106060-00001.
Influence of thyroid dysfunction on drug pharmacokinetics.
Shenfield G
Clin Pharmacokinet. 1981; 6(4):275-97.
PMID: 6166422
DOI: 10.2165/00003088-198106040-00003.
Estimate of volume/flow ratio of gastrointestinal (GI) fluids in humans using pharmacokinetic data.
Macheras P, Reppas C, Dressman J
Pharm Res. 1990; 7(5):518-22.
PMID: 2367321
DOI: 10.1023/a:1015825018361.
Pharmacokinetics of propylthiouracil in man after intravenous infusion.
Kampmann J
J Pharmacokinet Biopharm. 1977; 5(5):435-43.
PMID: 925880
DOI: 10.1007/BF01061727.
Drug metabolism in thyroid disease.
Eichelbaum M
Clin Pharmacokinet. 1976; 1(5):339-50.
PMID: 797503
DOI: 10.2165/00003088-197601050-00002.
A linear recirculation model for drug disposition.
Cutler D
J Pharmacokinet Biopharm. 1979; 7(1):101-16.
PMID: 458553
DOI: 10.1007/BF01059445.
Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs.
Bell J, Russell C, Nelson J, Kelly J, McDevitt D
Br J Clin Pharmacol. 1977; 4(1):79-82.
PMID: 14661
PMC: 1428989.
DOI: 10.1111/j.1365-2125.1977.tb00672.x.
